CT MPJE flashcards

32 cards. Read the term and the definition here. The deck at the top of this page is optional.

Connecticut pharmacist licensure

A Connecticut pharmacist license is issued by the Department of Consumer Protection; the Board of Pharmacy advises DCP. Practicing pharmacy without a license is prohibited.

Pharmacy technician registration

Connecticut requires pharmacy technicians to register with the Department of Consumer Protection. Technicians perform delegated tasks under pharmacist supervision; pharmacists retain responsibility for final verification and counseling.

Pharmacist immunization authority

Connecticut pharmacists who meet training and protocol requirements may administer vaccines under a valid prescriber order or authorized protocol and must document administration and report to the state registry as required.

Collaborative practice agreement

A written agreement between a Connecticut pharmacist and prescriber that authorizes pharmacist management of drug therapy under specified conditions, with documentation and communication requirements defined by Connecticut law.

Prescription minimum elements

A valid prescription identifies the patient, date, drug name, strength, dosage form, quantity, directions, prescriber, refills, and, for controlled substances, the prescriber's DEA number.

Generic substitution

Connecticut permits a pharmacist to substitute a therapeutically equivalent generic unless the prescriber indicates brand medically necessary or the patient refuses; the label must reflect the substitution as required.

Prescription label requirements

A Connecticut prescription label must show pharmacy name and address, prescription number, date, patient, prescriber, drug name and strength, directions, quantity, expiration date, and required warnings.

Refill limits

Schedule II prescriptions may not be refilled. Schedule III through V prescriptions may be refilled up to five times within six months of the issue date unless the prescriber specifies fewer.

PMP reporting

Connecticut dispensers must report controlled substance dispensing to the Connecticut Prescription Monitoring Program, generally by the next business day, including patient, prescriber, drug, quantity, and date information.

Emergency CII dispensing

If a Schedule II prescription cannot be obtained in writing or electronically, a pharmacist may dispense an emergency oral order if the prescriber provides a written or electronic prescription within seven days.

Opioid acute pain limit

Connecticut limits an initial opioid prescription for acute pain to a seven-day supply, subject to statutory exceptions such as cancer, palliative care, or chronic pain treatment.

Naloxone pharmacist dispensing

Connecticut pharmacists may dispense naloxone under a standing order or protocol to persons at risk of opioid overdose and must provide required education and documentation.

Offer to counsel

The pharmacist must offer counseling for each new prescription and when requested, covering drug name, directions, precautions, interactions, and storage; refusal should be documented per policy.

Prospective DUR

Before dispensing, the pharmacist screens for therapeutic duplication, drug-drug interactions, allergies, contraindications, incorrect dose or duration, and abuse or misuse, then resolves concerns with the prescriber.

Counseling documentation

When counseling is provided or refused, the pharmacy record should document the date, pharmacist, topics, and patient response as required by pharmacy policy and Connecticut recordkeeping rules.

REMS counseling

For drugs subject to a Risk Evaluation and Mitigation Strategy, the pharmacist must follow required enrollment, counseling, and safe-use conditions before dispensing; otherwise dispensing may be prohibited.

USP 795 BUD

USP <795> sets default beyond-use dates for nonsterile compounded preparations based on preservation, water activity, and storage; longer dates require stability information and documented justification.

USP 797 sterile conditions

Sterile compounding under USP <797> requires an ISO-classified cleanroom, validated air quality, trained personnel, proper garb, environmental monitoring, and documented cleaning and process controls.

Master formulation record

A master formulation record lists ingredients, quantities, equipment, compounding procedure, beyond-use date, and labeling for a compounded preparation and is used consistently for each batch.

Compounding record

The compounding record documents the specific batch: component lot numbers and expiration dates, quantities used, compounded and verified by, date, final yield, and assigned beyond-use date.

Controlled substance records

Federal law requires controlled substance records, including receipts, dispensings, inventories, and disposal documents, to be maintained for at least two years and be readily retrievable for DEA inspection.

Biennial inventory

Every registrant must take a controlled substance inventory every two years; Schedule II requires an exact count, while Schedules III-V may be estimated if the container holds more than 1,000 units.

DEA Form 222

DEA Form 222 or its electronic CSOS equivalent is required to order Schedule II controlled substances; the form must be completed, retained, and matched to received product.

DSCSA records

DSCSA requires transaction information, transaction history, and transaction statements to be retained for six years and made available to FDA or authorized trading partners upon request.

Consultant pharmacist review

In long-term care facilities, a consultant pharmacist must review each resident's medication regimen at least monthly and report irregularities to the attending physician and facility.

Unit-dose system

A unit-dose distribution system packages each dose separately and requires pharmacist review of orders, medication administration records, and cart exchange or automated dispensing oversight.

Emergency kit

A long-term care emergency medication kit must be sealed, periodically checked by pharmacy, and used only under a prescriber order with documentation and prompt replacement.

Automated dispensing system

An automated dispensing system in an institutional setting must be secured, pharmacist-supervised, and use audit trails; access is limited to authorized personnel and reviewed for discrepancies.

FDCA adulteration

The Federal Food, Drug, and Cosmetic Act prohibits introducing adulterated or misbranded drugs into interstate commerce; pharmacies must dispense drugs that meet federal approval and labeling requirements.

DSCSA authorized partners

Under DSCSA, pharmacies may accept prescription drugs only from authorized trading partners, must verify suspect products, quarantine them, and notify FDA and the supplier.

REMS restrictions

A Risk Evaluation and Mitigation Strategy imposes safe-use conditions such as prescriber certification, pharmacy certification, patient enrollment, or counseling; dispensing outside REMS requirements violates federal law.

HIPAA minimum necessary

The HIPAA Privacy Rule requires covered entities to limit uses and disclosures of protected health information to the minimum necessary for the purpose, except for treatment and certain required disclosures.